[Yung Shin] March 2026 Revenue NT$620 Million (YoY -23.7%)
NQ Score
3/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Yung Shin Pharmaceutical announced its March 2026 monthly revenue was NT$620 million, a sharp decrease of 23.7% year-over-year. This indicates challenges in the biotechnology and medical care industry.